Sort   by:  
 Page size 
UnknownCurcumin enhances ATG3-dependent autophagy and inhibits metastasis in cervical carcinoma.
Not available
S-EPMC11606299 | biostudies-literature
UnknownMicroRNA-10a is down-regulated by DNA methylation and functions as a tumor suppressor in gastric cancer cells.
Not available
S-EPMC3909310 | biostudies-literature
UnknownSurgical outcomes from haematoma evacuation for intracerebral haemorrhage in the INTERACT3 study.
Not available
S-EPMC12414919 | biostudies-literature
UnknownAn open label, multicenter, noninterventional study of apatinib in advanced gastric cancer patients (AHEAD-G202).
Not available
S-EPMC7082876 | biostudies-literature
UnknownSafety and effectiveness of apatinib in patients with previously treated metastatic gastric cancer: a sub-analysis from the real-world study of apatinib for gastric cancer treatment (AHEAD-G202).
Not available
S-EPMC7136926 | biostudies-literature
UnknownSafety and effectiveness of apatinib in elderly patients with metastatic gastric cancer: a sub-analysis from the large-scale, prospective observational study of apatinib for gastric cancer treatment in a real-world clinical setting (AHEAD-G202).
Not available
S-EPMC9459208 | biostudies-literature
UnknownRepurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
Not available
S-EPMC7727327 | biostudies-literature
UnknownFrailty, Multimorbidity, and Polypharmacy: Exploratory Analyses of the Effects of Empagliflozin from the EMPA-KIDNEY Trial.
Not available
S-EPMC11390031 | biostudies-literature
UnknownImpact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial.
Not available
S-EPMC7618536 | biostudies-literature
UnknownEmpagliflozin in Patients with Chronic Kidney Disease.
Not available
S-EPMC7614055 | biostudies-literature
Sort   by:  
 Page size